Actively Recruiting
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Led by Regeneron Pharmaceuticals · Updated on 2026-05-11
1200
Participants Needed
45
Research Sites
78 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is researching experimental drugs called REGN7508 and REGN9933. The study is focused on participants who have atrial fibrillation, which means that the heart beats too fast and unevenly. REGN7508 and REGN9933 are designed to help stop blood clots forming in patients with atrial fibrillation. The aim of the study is to see how well REGN7508 and REGN9933 work in patients that get medicine for their atrial fibrillation. The bleeding effects of REGN7508 and REGN9933 will be compared to another medicine (apixaban), which is available on the market to treat and prevent formation of blood clots. The study is looking at several other research questions, including: * What side effects may happen from taking REGN7508 or REGN9933 * How well do the study drugs reduce the risk of having a stroke * How much of REGN7508 or REGN9933 is in the blood at different times * Whether the body makes antibodies against REGN7508 or REGN9933 (which could make the drugs less effective or could lead to side effects)
CONDITIONS
Official Title
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Who Can Participate
Eligibility Criteria
You may qualify if you...
Key
-
Has AF or flutter (paroxysmal or persistent), not felt to be secondary to a reversible cause, and an indication for indefinite anticoagulation treatment as described in the protocol
-
Meets one of the following:
- CHA2DS2-VA [C: Congestive heart failure; H: Hypertension; A2: Age ≥75 years (double points); D: Diabetes mellitus; S2: Stroke or TIA or Thromboembolism (double points); V: Vascular disease; A: Age 65-74 years] score ≥2 and Oral Anticoagulant (OAC) naïve or
- CHA2DS2-VA score ≥3 or
- CHA2DS2-VA score of 2 and at least 1 enrichment criteria as described in the protocol
-
Must have an International Normalization Ratio (INR) <2.5 at the time of randomization if taking warfarin or another Vitamin K Antagonist (VKA)
Key
You will not qualify if you...
- Has a mechanical heart valve prosthesis (Note: transcatheter aortic valve replacement is not an exclusion)
- Has known moderate-to-severe mitral stenosis
- Has had successful ablation therapy or Left Atrial Appendage (LAA) occlusion/exclusion, or planned ablation or LAA occlusion/exclusion as described in the protocol
- Had an ischemic stroke within 2 days prior to randomization
- Has estimated Glomerular Filtration Rate (eGFR) <15 mL/min/1.73m^2 within 30 days prior to randomization or on dialysis or expected to be started as described in the protocol
- Has a history of central nervous system bleeding within 30 days prior to randomization
Note: Other protocol-defined Inclusion/ Exclusion criteria apply
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 45 locations
1
SEC Clinical Research
Dothan, Alabama, United States, 36305
Actively Recruiting
2
Eastern Shore Research Institute
Fairhope, Alabama, United States, 36532
Actively Recruiting
3
Mission Cardiovascular Research Institute
Fremont, California, United States, 94538
Actively Recruiting
4
National Institute of California Heart and Vein Specialists
Huntington Beach, California, United States, 92648
Actively Recruiting
5
Profound Research LLC at Southern California Heart Specialists
Pasadena, California, United States, 91105
Actively Recruiting
6
Empire Clinical Research
Pomona, California, United States, 91767
Actively Recruiting
7
Northbay Clinical Research Center
Santa Rosa, California, United States, 95405
Actively Recruiting
8
Cardiology Associates Medical Group
Ventura, California, United States, 93003
Actively Recruiting
9
Interventional Cardiology Medical Group
West Hills, California, United States, 91307
Actively Recruiting
10
Nouvelle Clinical Research LLC
Cutler Bay, Florida, United States, 33189
Actively Recruiting
11
Inpatient Research Clinic LLC
Miami Lakes, Florida, United States, 33014
Actively Recruiting
12
Cardiovascular Center of Sarasota Foundation for Research and Education
Sarasota, Florida, United States, 34239
Actively Recruiting
13
Clinical Site Partners, LLC DBA Flourish Research
Winter Park, Florida, United States, 32789
Actively Recruiting
14
Health Sciences Research Building II
Atlanta, Georgia, United States, 30322
Actively Recruiting
15
NSC Research, Inc
Johns Creek, Georgia, United States, 30024
Actively Recruiting
16
Indiana University
Indianapolis, Indiana, United States, 46202
Actively Recruiting
17
Blue Coast Research Center, LLC
Indianapolis, Indiana, United States, 46237
Actively Recruiting
18
Franciscan Physician Network, Indiana Heart Physicians
Indianapolis, Indiana, United States, 46237
Actively Recruiting
19
Indiana Medical Research
Merrillville, Indiana, United States, 46410
Actively Recruiting
20
Reid Physician Associates
Richmond, Indiana, United States, 47374
Actively Recruiting
21
Monroe Research, LLC
West Monroe, Louisiana, United States, 71291
Actively Recruiting
22
Anderson Medical Research
Ft. Washington, Maryland, United States, 20744
Actively Recruiting
23
Beth Israel Lahey Health, Beth Israel Deaconess Medical Center (BIDMC)
Boston, Massachusetts, United States, 02215
Actively Recruiting
24
Profound Research LLC
Farmington Hills, Michigan, United States, 48334
Actively Recruiting
25
AA Medical Research Center (MRC)
Flint, Michigan, United States, 48504
Actively Recruiting
26
Moses Cone Hospital Operating Corporation dba Cone Health, Lebauer-Brodie Center for Cardiovascular Research
Greensboro, North Carolina, United States, 27401
Actively Recruiting
27
K&R Research LLC
Marion, Ohio, United States, 43302
Actively Recruiting
28
Advanced Medical Research
Maumee, Ohio, United States, 43537
Actively Recruiting
29
Monument Health Clinical Research
Rapid City, South Dakota, United States, 57701
Actively Recruiting
30
East Coast Institute for Research, Jefferson City
Jefferson City, Tennessee, United States, 37760
Actively Recruiting
31
PharmaTex Research
Amarillo, Texas, United States, 79106
Actively Recruiting
32
Complete Heart Care P.A.
McKinney, Texas, United States, 75071
Actively Recruiting
33
Permian Research Foundation
Odessa, Texas, United States, 79761
Actively Recruiting
34
Tyler Cardiovascular Consultants
Tyler, Texas, United States, 75701
Actively Recruiting
35
Alpine Research TC
Clinton, Utah, United States, 84015
Actively Recruiting
36
University of Alberta Hospital - Cardiology
Edmonton, Alberta, Canada, T6G 2G3
Actively Recruiting
37
GA Research Associates Ltd.
Moncton, New Brunswick, Canada, E1G-1A7
Actively Recruiting
38
Health sciences North - Cardiology
Greater Sudbury, Ontario, Canada, P3E 5J1
Actively Recruiting
39
Dr James Cha
Oshawa, Ontario, Canada, L1J 2K1
Actively Recruiting
40
Heart Health Institute Research Inc. - Cardiology
Scarborough Village, Ontario, Canada, M1B 4Z8
Actively Recruiting
41
Viacar Recherches Cliniques Inc. - Cardiologie
Longueuil, Quebec, Canada, J4H 4B9
Actively Recruiting
42
Centre Hospitalier Universitaire De Sherbrooke (CHUS) - Cardiologie
Sherbrooke, Quebec, Canada, J1H 5N4
Actively Recruiting
43
Diex Recherche Inc.
Sherbrooke, Quebec, Canada, J1LOK3
Actively Recruiting
44
Diex Recherche Trois-rivieres
Trois-Rivières, Quebec, Canada, G9A 4P3
Actively Recruiting
45
CHU de Quebec-Universite Laval
Québec, Canada, G1R 2J6
Actively Recruiting
Research Team
C
Clinical Trials Administrator
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here